Published in Nat Immunol on August 29, 2010
The interleukin-1 family: back to the future. Immunity (2013) 3.90
Molecular basis of NF-κB signaling. Annu Rev Biophys (2013) 2.03
Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces. Nat Commun (2014) 1.59
IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. Mol Cell (2014) 1.52
Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation. Immunity (2013) 1.26
Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Sci Signal (2012) 1.20
The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines. Front Immunol (2013) 1.14
Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A (2013) 1.09
Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol (2012) 1.06
Neutrophils, IL-1β, and gout: is there a link? Semin Immunopathol (2013) 0.98
Kainic acid-induced neurodegenerative model: potentials and limitations. J Biomed Biotechnol (2010) 0.98
Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily. Front Immunol (2013) 0.96
Structural biology of innate immunity. Annu Rev Immunol (2015) 0.93
GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain (2015) 0.88
A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases. Self Nonself (2011) 0.87
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes. Mol Ther Methods Clin Dev (2014) 0.84
Design of a superior cytokine antagonist for topical ophthalmic use. Proc Natl Acad Sci U S A (2013) 0.84
Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol (2016) 0.83
The structural basis for receptor recognition of human interleukin-18. Nat Commun (2014) 0.83
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist. J Neuroinflammation (2014) 0.82
Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses. Protein Sci (2014) 0.81
Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra. J Mol Biol (2013) 0.81
Caspase-1 and IL-1β processing in a teleost fish. PLoS One (2012) 0.81
Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial. PLoS One (2013) 0.80
The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β. MAbs (2015) 0.79
Accessory to inflammation. Nat Immunol (2010) 0.79
Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Cancers (Basel) (2014) 0.79
Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method. PLoS One (2015) 0.78
A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue. Schizophr Bull (2015) 0.77
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol (2016) 0.76
Mechanisms of splicing-dependent trans-synaptic adhesion by PTPδ-IL1RAPL1/IL-1RAcP for synaptic differentiation. Nat Commun (2015) 0.76
IL-1 receptor accessory protein-Ig/IL-1 receptor type II-Ig heterodimer inhibits IL-1 response more strongly than other IL-1 blocking biopharmaceutical agents. J Clin Immunol (2010) 0.76
Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain. PLoS One (2016) 0.75
Structure and function of chicken interleukin-1 beta mutants: uncoupling of receptor binding and in vivo biological activity. Sci Rep (2016) 0.75
A new and robust method of tethering IgG surrogate antigens on lipid bilayer membranes to facilitate the TIRFM based live cell and single molecule imaging experiments. PLoS One (2013) 0.75
Structural and Functional Attributes of the Interleukin-36 Receptor. J Biol Chem (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr (2002) 27.16
Biologic basis for interleukin-1 in disease. Blood (1996) 16.04
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Version 1.2 of the Crystallography and NMR system. Nat Protoc (2007) 13.01
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature (1985) 9.81
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A (1984) 8.84
Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29
The IL-1 family: regulators of immunity. Nat Rev Immunol (2010) 4.65
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 4.14
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (1993) 3.62
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
The IL-1 family and inflammatory diseases. Clin Exp Rheumatol (2004) 3.10
A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J (1991) 2.85
Purification and characterization of the human interleukin-18 receptor. J Biol Chem (1997) 2.58
Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem (1995) 2.58
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol (2007) 2.22
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci U S A (2000) 2.03
Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem (1998) 1.99
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature (1997) 1.83
The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol Today (1994) 1.83
IL-1: discoveries, controversies and future directions. Eur J Immunol (2010) 1.73
The interleukin-1 receptor family. Vitam Horm (2006) 1.65
The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity (2003) 1.61
Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. Proc Natl Acad Sci U S A (1989) 1.56
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature (1997) 1.50
A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol (1997) 1.43
The structure and binding mode of interleukin-18. Nat Struct Biol (2003) 1.42
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov (2004) 1.38
Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci (2009) 1.25
Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes. Structure (2009) 1.24
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol (1998) 1.24
Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci U S A (2008) 1.13
IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol (1998) 1.12
The many worlds of reducing interleukin-1. Arthritis Rheum (2005) 1.10
Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett (2001) 1.05
Identification of amino acid residues critical for biological activity in human interleukin-18. J Biol Chem (2002) 1.05
Structure-function relationship in the IL-1 family. Front Biosci (1996) 1.01
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc Natl Acad Sci U S A (1991) 0.94
Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett (1998) 0.90
X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J Biol Chem (2000) 0.87
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. J Biol Chem (1995) 0.85
Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J Biol Chem (2009) 0.85
Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Cytokine (1994) 0.82
Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J Immunol (1998) 0.82
Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance. Eur Cytokine Netw (1997) 0.81
Structure-activity relationships in human interleukin-1 alpha: identification of key residues for expression of biological activities. Protein Eng (1992) 0.80
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell (2009) 4.48
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res (2013) 3.20
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell (2012) 2.96
Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy (2011) 2.47
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42
Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics. Lab Chip (2008) 2.11
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Mayo Clin Proc (2005) 2.00
Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc (2012) 1.98
The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.96
Identification of bacteria using tandem mass spectrometry combined with a proteome database and statistical scoring. Anal Chem (2004) 1.89
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol (2008) 1.88
SlipChip. Lab Chip (2009) 1.84
Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg (2006) 1.80
Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res (2010) 1.77
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71
Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level. World J Gastroenterol (2004) 1.70
Core/Shell semiconductor nanocrystals. Small (2009) 1.68
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A (2007) 1.61
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prev Res (Phila) (2011) 1.61
Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials. Endocrine (2014) 1.58
Protein sequencing by mass analysis of polypeptide ladders after controlled protein hydrolysis. Nat Biotechnol (2004) 1.56
The structure of interleukin-2 complexed with its alpha receptor. Science (2005) 1.53
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med (2014) 1.52
Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. J Immunol (2012) 1.50
One-Step UV-Induced Synthesis of Polypyrrole/Ag Nanocomposites at the Water/Ionic Liquid Interface. Nanoscale Res Lett (2009) 1.50
Tactile, acoustic and vestibular systems sum to elicit the startle reflex. Neurosci Biobehav Rev (2002) 1.47
Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors. Leuk Res (2012) 1.46
Three-layer reconstruction of large urethrocutaneous fistulas using scrotal-septal flaps. Can Urol Assoc J (2014) 1.45
Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem (2009) 1.44
Lymphatic function is required prenatally for lung inflation at birth. J Exp Med (2014) 1.44
Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One (2012) 1.44
Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients. Pharmacogenet Genomics (2009) 1.41
Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Blood (2005) 1.41
A few-view reweighted sparsity hunting (FRESH) method for CT image reconstruction. J Xray Sci Technol (2013) 1.40
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. Crit Care Med (2016) 1.40
Synthesis and cytotoxic activities of novel phenacylimidazolium bromides. Bioorg Med Chem Lett (2009) 1.36
Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials. J Thorac Oncol (2010) 1.36
Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China. J Biol Chem (2011) 1.33
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res (2011) 1.32
Fabrication of high-quality In2Se3 nanowire arrays toward high-performance visible-light photodetectors. ACS Nano (2010) 1.31
Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg (2009) 1.30
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol (2009) 1.29
Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One (2010) 1.28
Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health (2012) 1.27
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res (2011) 1.26
China's first rare-disease registry is under development. Lancet (2011) 1.23
ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol Cell Proteomics (2003) 1.22
MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol (2013) 1.22
Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One (2011) 1.21
Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics (2003) 1.21
Stable-isotope dimethylation labeling combined with LC-ESI MS for quantification of amine-containing metabolites in biological samples. Anal Chem (2007) 1.19
Differential dimethyl labeling of N-termini of peptides after guanidination for proteome analysis. J Proteome Res (2005) 1.19
Identification of mammalian proteins cross-linked to DNA by ionizing radiation. J Biol Chem (2005) 1.18
The protective role of hydrogen-rich saline in experimental liver injury in mice. J Hepatol (2010) 1.17
Chromatographic fingerprint analysis of Cephalotaxus sinensis from various sources by high-performance liquid chromatography-diodearray detection-electrospray ionization-tandem mass spectrometry. J Pharm Biomed Anal (2007) 1.17
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother (2011) 1.15
Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg (2006) 1.15
Crystal structures and magnetic and luminescent properties of a series of homodinuclear lanthanide complexes with 4-cyanobenzoic ligand. Inorg Chem (2006) 1.15
Seroprevalence of avian influenza A (H5N1) virus among poultry workers in Jiangsu Province, China: an observational study. BMC Infect Dis (2012) 1.14
Palladium-catalyzed sequential arylation and allylic alkylation of highly functionalized ketones: a concise synthesis of mesembrine. Org Lett (2009) 1.14
Structural basis for R-spondin recognition by LGR4/5/6 receptors. Genes Dev (2013) 1.13
Mitogen-activated protein kinase-dependent activation of the Na+/H+ exchanger is mediated through phosphorylation of amino acids Ser770 and Ser771. J Biol Chem (2007) 1.13
Embryonic stem cell markers. Molecules (2012) 1.13
Effect of functional health-related quality of life on long-term survival after cardiac surgery. Circulation (2007) 1.13
Gametophytic and zygotic selection leads to segregation distortion through in vivo induction of a maternal haploid in maize. J Exp Bot (2013) 1.12
Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res (2005) 1.11
Effects of common surfactants on protein digestion and matrix-assisted laser desorption/ionization mass spectrometric analysis of the digested peptides using two-layer sample preparation. Rapid Commun Mass Spectrom (2004) 1.11
Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol (2004) 1.10
The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. Acta Neuropathol (2002) 1.10
Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J Biol Chem (2011) 1.10
Single-crystalline Sb₂Se₃ nanowires for high-performance field emitters and photodetectors. Adv Mater (2010) 1.10
Size-tailored ZnO submicrometer spheres: bottom-up construction, size-related optical extinction, and selective aniline trapping. Adv Mater (2011) 1.10
Myocardin regulates BMP10 expression and is required for heart development. J Clin Invest (2012) 1.10
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe. Clin Cancer Res (2009) 1.10
UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol Cancer Ther (2008) 1.09
Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A (2013) 1.09
Development of mass spectrometry-based shotgun method for proteome analysis of 500 to 5000 cancer cells. Anal Chem (2010) 1.08
Neural representations of close others in collectivistic brains. Soc Cogn Affect Neurosci (2011) 1.08
Using three-phase flow of immiscible liquids to prevent coalescence of droplets in microfluidic channels: criteria to identify the third liquid and validation with protein crystallization. Langmuir (2007) 1.08
Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer (2011) 1.07
Fine mapping of the grain chalkiness QTL qPGWC-7 in rice (Oryza sativa L.). Theor Appl Genet (2008) 1.07
Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem (2007) 1.07
Myofibroblastic sarcomas: a clinicopathological study of 20 cases. Chin Med J (Engl) (2007) 1.07
BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia. Cancer Res (2007) 1.07
4-{2-[4-(Dimethyl-amino)-phen-yl]ethen-yl}-1-methyl-pyridinium 3,5-dicarb-oxy-benzene-sulfonate methanol monosolvate. Acta Crystallogr Sect E Struct Rep Online (2012) 1.07
Comparison of SDS- and methanol-assisted protein solubilization and digestion methods for Escherichia coli membrane proteome analysis by 2-D LC-MS/MS. Proteomics (2007) 1.07
Thermal properties of bi nanowire arrays with different orientations and diameters. J Phys Chem B (2006) 1.06
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? J Thorac Cardiovasc Surg (2013) 1.06
Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Exp Cell Res (2004) 1.05
Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg (2014) 1.05